SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration with the Brain Health Alliance as an imaging site in the nationwide EPSMS Study—a groundbreaking clinical trial utilizing whole-body PET imaging to study multiple sclerosis.

The EPSMS Study (Entire-body PET Scans for Multiple Sclerosis) is a novel research initiative exploring how advanced molecular imaging can provide new insights into the demyelination and remyelination processes in MS patients. CMIT is now the second imaging site approved to begin scanning participants, joining Northern California PET Imaging Center (NCPIC) in Sacramento, Calif.

“This collaboration places Shreveport at the forefront of innovative MS research,” said Stephen Lokitz, Ph.D., CMIT ex

See Full Page